Correlation Between Xilio Development and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Xilio Development and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xilio Development and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xilio Development and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Xilio Development and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xilio Development with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xilio Development and Crinetics Pharmaceuticals.
Diversification Opportunities for Xilio Development and Crinetics Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Xilio and Crinetics is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Xilio Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xilio Development are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Xilio Development i.e., Xilio Development and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Xilio Development and Crinetics Pharmaceuticals
Considering the 90-day investment horizon Xilio Development is expected to under-perform the Crinetics Pharmaceuticals. In addition to that, Xilio Development is 4.74 times more volatile than Crinetics Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest 5,715 in Crinetics Pharmaceuticals on August 28, 2024 and sell it today you would lose (106.00) from holding Crinetics Pharmaceuticals or give up 1.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Xilio Development vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Xilio Development |
| Crinetics Pharmaceuticals |
Xilio Development and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xilio Development and Crinetics Pharmaceuticals
The main advantage of trading using opposite Xilio Development and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xilio Development position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
| Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. HCW Biologics | Crinetics Pharmaceuticals vs. Scpharmaceuticals | Crinetics Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |